Vanguard Group Inc Sarepta Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,967,552 shares of SRPT stock, worth $1.09 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,967,552
Previous 9,035,624 0.75%
Holding current value
$1.09 Billion
Previous $1.43 Billion 21.54%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$124.33 - $156.75 $8.46 Million - $10.7 Million
-68,072 Reduced 0.75%
8,967,552 $1.12 Billion
Q2 2024

Aug 13, 2024
BUY
$113.33 - $163.85 $27.2 Million - $39.3 Million
239,870 Added 2.73%
9,035,624 $1.43 Billion
Q1 2024

May 10, 2024
SELL
$93.7 - $141.53 $1.91 Million - $2.88 Million
-20,370 Reduced 0.23%
8,795,754 $1.14 Billion
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $16.4 Million - $30.3 Million
243,180 Added 2.84%
8,816,124 $850 Million
Q3 2023

Nov 14, 2023
BUY
$102.5 - $123.59 $4.25 Million - $5.12 Million
41,465 Added 0.49%
8,572,944 $1.04 Billion
Q2 2023

Aug 14, 2023
BUY
$106.4 - $157.19 $44.5 Million - $65.8 Million
418,515 Added 5.16%
8,531,479 $977 Million
Q1 2023

May 15, 2023
BUY
$117.53 - $155.99 $9.37 Million - $12.4 Million
79,700 Added 0.99%
8,112,964 $1.12 Billion
Q4 2022

Feb 10, 2023
SELL
$100.86 - $132.13 $5.27 Million - $6.9 Million
-52,253 Reduced 0.65%
8,033,264 $1.04 Billion
Q3 2022

Nov 14, 2022
SELL
$75.71 - $119.24 $25.3 Million - $39.9 Million
-334,530 Reduced 3.97%
8,085,517 $894 Million
Q2 2022

Aug 12, 2022
BUY
$62.69 - $88.44 $6.57 Million - $9.27 Million
104,865 Added 1.26%
8,420,047 $631 Million
Q1 2022

May 13, 2022
BUY
$63.15 - $90.42 $257,273 - $368,371
4,074 Added 0.05%
8,315,182 $650 Million
Q4 2021

Feb 14, 2022
BUY
$77.28 - $99.42 $64.2 Million - $82.6 Million
830,457 Added 11.1%
8,311,108 $748 Million
Q3 2021

Nov 12, 2021
BUY
$65.97 - $92.48 $1.6 Million - $2.24 Million
24,249 Added 0.33%
7,480,651 $692 Million
Q2 2021

Aug 13, 2021
BUY
$69.38 - $86.75 $517 Million - $647 Million
7,456,402 New
7,456,402 $580 Million

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
84.2M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email